digitalstudios

About digitalstudios

This author has not yet filled in any details.
So far digitalstudios has created 4530 blog entries.

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

GV101, is a novel, highly selective ROCK2 inhibitor, yielded an [...]

By |2026-08-26T15:04:44+00:00August 26, 2026|3rd Party Medical Device Industry News|Comments Off on Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
Go to Top